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a b s t r a c t
Measles has been reemerging in South Korea since December 2018 resulting in 185 cases by September
2019.
We calculated contact-adjusted immunity levels against measles in South Korea using national sero-
prevalence data in 2014, vaccination uptake rates, and an age-specific contact matrix. We further
explored options to achieve a contact-adjusted immunity level of 93% for herd immunity.
The assessed contact-adjusted immunity level has increased from 86% in 2014 to 92% in 2018. Herd
immunity could be achieved with immunizing 50% of susceptibles among birth cohorts 1999–2003 in
2018.
Contact-adjusted immunity levels against measles have increased recently in South Korea, although
they might not yet be high enough to guarantee herd immunity.
 2019 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).
1. Introduction
Measles, a systemic viral illness, is one of the most contagious
diseases in humans. In the pre-vaccination era, approximately 2
million deaths worldwide were attributed to measles each year
[1]. Thanks to a highly effective vaccine introduced in 1963 and
intensive surveillance efforts, global measles incidence and mortal-
ity have gradually decreased [1]. During 2000–2015, the number of
deaths due to measles dropped by 76% from 550,100 in 2000 to
134,200 in 2015 [1].
In South Korea, measles-containing vaccines (MCV) were first
introduced in 1965. A single dose (MCV1) at 15 months of age
was introduced in the National Immunization Program (NIP) in
1983. In 1997, NIP recommended MCV1 at 12–15 months of age
and a second dose (MCV2) at 4–6 years of age with no catch-up
[2]. The annual incidence of measles fell dramatically from
30,792 cases (11.6 cases per million persons) in 1962 to a low of
2 cases in 1997 [3].
However, in 2000–2001, a measles epidemic occurred that
resulted in more than 50,000 cases. Following this outbreak, the
Korean government announced a ‘‘Five Year Measles Elimination
Program” that included a catch-up vaccination program targeting
8–16 year olds (birth cohorts March 1985 to Feb 1994, 5.8 million)
and a keep-up program that required all children entering elemen-
tary school to present evidence of two-dose MCV vaccination [2,4].
This effort reduced the annual incidence of measles to less than
one per million, and, in 2006, South Korea became the first country
in Western Pacific to declare elimination of measles [2].
The capacity of the measles virus to infect respiratory epithe-
lium and release viral progeny into the airway plays a role in its
high infectivity. The basic reproduction number (R0) is often cited
to be between 12 and 18 for measles, although a wider range of
values is possible [5]. The herd immunity level to prevent measles
outbreaks requires immunity of 90 to 95% based on these values of
R0, the highest of all vaccine-preventable directly transmitted dis-
eases [5]. When taking into account differences in contact behav-
ior, this can be achieved by ensuring that at least 85% of those
aged 5 years or less are immune, and 95% of all age groups above
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5 years of age [6]. Outbreaks might occur when the proportion of
the population immune to measles through vaccination or prior
infection drops below these percentages.
Recently in South Korea, there has been an increase in cases of
measles since December 2018, and as of 28th of September 2019, a
total of 185 laboratory confirmed measles cases were reported [7].
This increase occurred in spite of reported two-dose coverage over
95% since 2010 [8].
In this study, we review the changes in measles seroprevalence
and vaccination uptake rate to estimate contact-adjusted immu-
nity levels from age-specific contact patterns, which have been
widely used for transmission modelling [9]. We further explore
options for catch-up campaigns that might achieve sufficient levels
of population immunity to maintain measles elimination.
2. Methods
2.1. Data
We used publicly available data sets of age-specific incidence of
measles in South Korea [7,10,11]. For age-specific seroprevalence
data, we used data from a nation-wide measles seroprevalence
study that was conducted by KCDC in 2014 [12]. Briefly, 3050
serum samples (1000 from aged <10 years and 2050 from aged
10–50 years, birth cohorts 1964–2014) were provided by the fifth
Korea National Health and Nutrition Examination Survey
(KNHANES VI-1st) [13]. Measles virus-specific immunoglobulin G
(IgG) antibodies were tested by an enzyme immunoassay. Equivo-
cal results were interpreted as positive. For vaccine coverage data,
we used WHO/UNICEF Estimates of National Immunization Cover-
age (WUENIC) [8].
2.2. Age-specific immunity levels
We estimated age-specific immunity levels by combining the
seroprevalence data in 2014 with vaccine coverage data for birth
cohorts following 2014 [12]. For those under 1 year of age at the
end of 2018, we assumed that immunity levels were the same as
for those under 1 year of age in 2014. For 1-year olds, we assumed
that the proportion of children immune at any time compared to
coverage at the end of the year would be the same in 2018 as that
in 2014. For those aged 2 to 5, we assumed that their immunity
was in accordance with the reported first-dose vaccination uptake
between 2014 and 2017, with a vaccine efficacy of 95%. For those
aged 6 or older, we used the seroprevalence levels from the KCDC
study [12] shifted by 4 years and adjusted immunity levels by
reported second-dose vaccination uptake (assuming that the sec-
ond dose was given to those that had already received one dose),
before aggregating to age groups as given by the contact data, with
each single-year age group weighted according to population esti-
mates from 2014 and 2018, respectively, when averaging them to
estimate immunity in the larger age group containing multiple
years of age (Table 1) [14].
2.3. Contact matrix
Since social contact patterns of South Korea have not been
reported, we tried to find plausible substitutes. Among East Asian
countries, social mixing patterns relevant to the respiratory infec-
tions have been published for Taiwan, Japan and China [15–17].
Here, we adopted the number of contacts between age groups from
a Japanese study conducted in 2011 by Ibuka Y et al. with permis-
sion (Supplementary Fig. 1) [17].
Since we did not have access to a breakdown of contacts of 20–
29 year olds into smaller age groups but identified 20–24 year olds
as an age group of low seropositivity, we conducted sensitivity
analysis by splitting the 20–29 year old age groups in two halves,
with both having half the amount of contact that 20–29 year olds
have with 30–39 year olds with the other half of the age group,
and the rest within their own half of the age group.
2.4. Plain and contact-adjusted immunity
We calculated plain immunity levels as the overall proportion
of the population immune. We further combined immunity levels
with contact data to calculate contact-adjusted immunity levels
[18]. Contact-adjusted immunity r’ is given by
r
0 ¼ 1 R
R0
where R/R0 is the ratio of the effective reproduction number R to the
basic reproduction number R0.
In an age-structured population, the basic reproduction number
is related to the contact matrix via
R0 ¼ q Kð Þ
where q denotes the spectral radius and K is a matrix with elements
kij ¼ /ij
Ni
Nj
where /ij is the number of contacts that an individual in age group i
makes with that in age group j, and Ni is the size of age group i. The
effective reproduction number R is obtained in the same way,
except that the matrix K is multiplied with a vector of susceptibility
to yield an effective matrix K0
k0 ij ¼ kijð1 riÞ
where ri is the proportion immune in age group i.
We considered 93% of contact-adjusted immunity to be the
threshold level for elimination (corresponding to a basic reproduc-
tive number R0 of 14.3), as in [18].
All analyses were conducted using the R statistical software ver-
sion 3.6.1. Contact-adjusted immunity levels were calculated using
the epimixr R package. Code and data to reproduce the analyses are
available as an R package at http://github.com/sbfnk/sk.measles.
Table 1
Proportion of the population who is immune to measles by different age groups with
original seroprevalence data (2014) and elapsed time adjusted data (2018), and their
contact-adjusted immunity levels in South Korea.
Age group (years) Proportion of Immune
Original (2014) Shifted (2018)
0–2 0.63 0.62
3–5 0.99 0.93
6–11 0.98 1.00
12–14 0.86 0.98
15–19 0.79 0.87
20–29 0.93 0.85
30–39 0.96 0.96
40–49 0.97 0.96
50 1.00 1.00
Plain immunitya 0.92 0.92
Contact-adjusted immunityb 0.86 0.92
Information based on publicly available national data conducted by Korea Centers
for Disease Control in 2014 [12].
a Plain immunity was calculated by overall proportion of the population immune.
b Contact-adjusted immunity was calculated as in [18].
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3. Results
3.1. Age distribution of measles in South Korea
Age distribution of measles cases according to years is shown in
Fig. 1. The proportion of all measles cases in those aged 5 years or
less was 71% in 1989, 35.7% in 2001, and 42.7% in 2014, while the
proportion of cases in those aged 20 years or more was 4.1% in
2001, and 24.7% in 2014.
3.2. Contact-adjusted immunity
The contact-adjusted immunity level estimated based on the
2014 seroprevalence data was 86%, corresponding to an effective
reproduction number of 1.7–2.5 if the basic reproduction number
R0 is assumed to be in the typical range of 12–18 [5]. The plain
population-averaged immunity level ignoring social mixing pat-
terns was 92%. Projecting these immunity levels to the end of
2018 resulted in estimated 92% of contact-adjusted immunity, cor-
responding to an effective reproduction number of 1.0–1.4 if the
basic reproduction number R0 is 12–18, and 92% plain immunity
(Table 1). Sensitivity analysis conducted by splitting the 20–
29 year age group in two halves yielded the same level of
immunity.
3.3. Scenarios
We tested alternative scenarios where we changed immunity
levels of each age group, to test the effect on contact-adjusted
immunity that could be achieved in vaccination campaigns. Immu-
nizing 50% of susceptibles in each age groups, the biggest effect
was achieved in the 15–19 year olds group (birth cohorts 1999–
2003), which led to adjusted immunity level of 93% from the per-
spective of 2018 (Fig. 2D). This is in contrast to the situation in
2014, when the greatest effect was also achieved in 15–19 year
olds (birth cohorts 1995–1999), but this would have raised
contact-adjusted immunity levels only to 89% (Fig. 2C).
4. Discussion
The seroprevalence data collected in 2014 indicated that there
was an immunity gap in birth cohorts 1993–2000 [12]. This immu-
nity gap has been reported in two serological studies conducted by
KCDC [12,19]. It is in line with currently observed age distribution
of measles, which is mainly concentrated in those aged over 20.
The low contact-adjusted population immunity of 86% in 2014 is
attributable to this gap generation, since those age groups were
at 14–21 year-old school age whose contact numbers are greater
than most other age groups. On the other hand, projecting immu-
nity levels to 2018 using vaccination coverage data leads to 92% of
contact-adjusted population immunity. It seems like the suscepti-
ble cohort has grown out of the school age and, consequently, the
risk of a large outbreak has been reduced. A caveat is that we do
not have a breakdown in contacts between 20 and 24 (where most
susceptibles are) and 25–29 year olds. While we did sensitivity
analysis to account for this, yielding no different results, we might
still underestimate assortative contacts of 20–24 year olds. Accord-
ing to national index data, percentage of students going to college
reaches 70% in South Korea, and this could cause higher contact
rates among those between 20 and 24 years of age [20].
While contact-adjusted immunity is increasing as susceptibles
are ageing out of the most contact-intense settings (especially
schools) and large outbreaks are thus less likely, the immunity
gap that continues to exist in certain birth cohorts still raise con-
cerns. If individuals in this age group become parents and get
infected with measles virus, then they could transmit the virus to
their susceptible infants.
To estimate the spread of respiratory transmissible disease such
as measles or influenza [17], understanding contact patterns
between individuals is important. Changes in contact patterns
might determine the transmission dynamic of the pathogen, such
as whether it will become epidemic or contained in an endemic
level. Infectious disease modelling based on these observed contact
patterns has repeatedly been shown to predict infectious disease
dynamics better than those based on random mixing [9,18].
Although this study provides insightful analysis for the current
measles outbreak in South Korea, there are some limitations. First,
the employed contact matrix is not of South Korea, but of a nearby
country, Japan. East Asian contact matrices from Taiwan, Japan and
China have shown similar contact patterns of age-assortative mix-
ing, leading us to assume South Korea might be comparable [15–
17]. Besides, the Japanese contact matrix was based on a retrospec-
tive survey, and as such may suffer from recall bias. It remains an
open question if diary-based studies of contact are sufficiently pre-
cise to warrant conducting country-specific mixing studies. If yes,
establishing a South Korean contact matrix may improve the accu-
racy of our analysis. Second, to gain up-to-date population immu-
nity levels from the seroprevalence study in 2014, we projected
immunity levels forward to 2018 with observed vaccination rates.
However, such projections are generally not as accurate as
observed national seroprevalence levels, as assumptions need to
be made on how exactly coverage translates to immunity levels
in different age groups. Further, we assumed that vaccine-
induced immunity against measles did not wane over time, but a
Fig. 1. Serial age distribution of measles in South Korea before (A) and after (B) the 2000–2001 outbreak. * denotes that the number includes suspected number of measles
cases, not only confirmed cases, since the outbreak is still ongoing.
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recent study suggested waning immunity against measles [12].
More seroprevalence studies would be needed to fully quantify
the risk of measles outbreaks in South Korea. Third, we interpreted
equivocal results of measles IgG as positive. If these were suscep-
tible to measles, population immunity would be lower (69%
contact-adjusted immunity in 2014, 83% in 2018).
Here, we presented contact-adjusted population immunity
against measles in South Korea. Furthermore, we propose target
age groups for catch-up campaigns to guarantee herd immunity.
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